首页> 美国卫生研究院文献>Infection and Immunity >Purification and partial characterization of outer membrane proteins P5 and P6 from Haemophilus influenzae type b.
【2h】

Purification and partial characterization of outer membrane proteins P5 and P6 from Haemophilus influenzae type b.

机译:b型流感嗜血杆菌外膜蛋白P5和P6的纯化和部分表征。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The major outer membrane proteins of Haemophilus influenzae type b (Hib), designated P5 and P6 (R.S. Munson, Jr., J.L. Shenep, S.J. Barenkamp, and D.M. Granoff, J. Clin. Invest. 72:677-684, 1983), were purified to homogeneity and partially characterized. P5 was insoluble in octylglucoside-NaCl and could be extracted with 1% sodium dodecyl sulfate (SDS) in 20 mM phosphate (pH 7.5). Solubilized P5 was further purified on hydroxylapatite in 0.1% SDS. The purified protein had an apparent molecular weight of 27,000 as determined by SDS-polyacrylamide gel electrophoresis after sample preparation at room temperature. The protein migrated with an apparent molecular weight of 35,000 after heating for 30 min at 100 degrees C in the presence of 10% beta-mercaptoethanol (beta ME). Rabbit antisera prepared against the purified preparation immunoprecipitated solubilized protein P5 but had no protective activity in the infant rat bacteremic model. The SDS-insoluble residue was further extracted with 1% SDS-0.5 M NaCl-0.1% beta ME at 37 degrees C. A single outer membrane protein, designated P6, with an apparent molecular weight of 16,000, remained insoluble under these conditions. Antiserum prepared against this insoluble fraction contained antibodies which, after removal of anti-lipopolysaccharide antibody, immunoprecipitated P6 and protected infant rats challenged with Hib. Protein P6 could be released from the insoluble cell wall in the presence of SDS-NaCl-beta ME at 60 degrees C. Thus, proteins P5 and P6 could be purified from the cell envelope of Hib. Based on the results from infant rat passive protection experiments, antigens in the P6-cell wall fraction merit further investigation as possible vaccine components. In contrast, epitopes on protein P5 did not appear to elicit protective antibody.
机译:b型流感嗜血杆菌(Hib)的主要外膜蛋白,命名为P5和P6(RS Munson,Jr.,JL Shenep,SJ Barenkamp和DM Granoff,J. Clin。Invest。72:677-684,1983),纯化至均质并部分表征。 P5不溶于辛基葡萄糖苷-NaCl,可以用20 mM磷酸盐(pH 7.5)中的1%十二烷基硫酸钠(SDS)萃取。溶解的P5在0.1%SDS中的羟磷灰石上进一步纯化。在室温下制备样品后,通过SDS-聚丙烯酰胺凝胶电泳测定,纯化的蛋白质的表观分子量为27,000。在10%β-巯基乙醇(βME)存在下于100摄氏度加热30分钟后,蛋白质以35,000的表观分子量迁移。针对纯化的制剂制备的兔抗血清免疫沉淀了可溶性蛋白P5,但在婴儿大鼠细菌模型中没有保护活性。在37℃下用1%SDS-0.5M NaCl-0.1%β-ME进一步萃取不溶于SDS的残基。在这些条件下,表观分子量为16,000的单个外膜蛋白称为P6,仍然不溶。针对这种不溶级分制备的抗血清含有抗体,该抗体在去除抗脂多糖抗体后会免疫沉淀P6并保护受Hib攻击的幼鼠。在60摄氏度下,存在SDS-NaCl-beta ME时,蛋白P6可以从不溶性细胞壁释放出来。因此,可以从Hib的细胞膜中纯化蛋白P5和P6。根据婴儿大鼠被动保护实验的结果,P6细胞壁部分中的抗原值得进一步研究,以作为可能的疫苗成分。相反,蛋白P5上的表位似乎没有引起保护性抗体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号